GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Rallis India Ltd
Rallis India Q2 FY27 Results: Revenue Flat, PAT Decreased by 17%
RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 22 Oct 2026, 07:15 PM IST  ·  BSE ID: 1f15e6be-b5c1-4490-ad3c-91dda25fb3a3
View Original BSE Filing (PDF)
💡
In Simple Terms
Rallis India's Q2 revenue remained flat, but its quarterly profits decreased, impacted by higher costs and seed returns.
🤖 AI Summary
  • Rallis India Ltd. submitted its Q2 and H1 FY27 financial results presentation.
  • Q2 FY27 revenue was Rs. 858 Cr., a marginal decrease from Rs. 861 Cr. in Q2 FY26.
  • EBITDA for Q2 FY27 decreased by 18% to Rs. 126 Cr. from Rs. 154 Cr. in Q2 FY26.
  • PAT for Q2 FY27 decreased by 17% to Rs. 85 Cr. from Rs. 102 Cr. in Q2 FY26.
  • Crop Care revenue increased by 4% YoY, while Seeds revenue decreased by 31% YoY in Q2 FY27.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue Q2 FY27
Rs. 858 Cr.
-0.35%
Revenue Q2 FY26
Rs. 861 Cr.
EBITDA Q2 FY27
Rs. 126 Cr.
-18.18%
EBITDA Q2 FY26
Rs. 154 Cr.
PAT Q2 FY27
Rs. 85 Cr.
-16.67%
PAT Q2 FY26
Rs. 102 Cr.
Crop Care Revenue Q2 FY27 YoY Growth
4%
Seeds Revenue Q2 FY27 YoY Decline
31%
B2B Exports including CSM Revenue Q2 FY27 YoY Growth
18%
🏢 How This Affects the Company
📈
Business Impact
The company reported a flat topline in Q2 FY27, influenced by the weakest monsoon since 2015 and challenging market conditions. Domestic Formulation Business revenue remained flat despite challenges, with Herbicides showing growth.
💰
Financial Impact
EBITDA decreased by 18% to Rs. 126 Cr. and PAT decreased by 17% to Rs. 85 Cr. in Q2 FY27, primarily due to input cost pressure in Crop Care and higher sales returns in Seeds.
⚙️
Operational Impact
Rallis India launched 4 new products in Q2 FY27 (2 Fungicides, 1 Herbicide, 1 Insecticide) and several new seed products in H1 FY27, expanding its portfolio. The Soil & Plant Health business registered 22% growth.
⚠️
Risk Impact
The company highlighted drought in several parts of the country and supply squeeze on bulk chemicals as key challenges impacting demand and farmer investments. A highly competitive and volatile pricing environment was also noted.
👥 What This Means For Shareholders
✅
Action Required
No action required by shareholders based on this results presentation.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with Q2 FY27 PAT decreasing by 17% to Rs. 85 Cr. from Rs. 102 Cr. in Q2 FY26.
🔍
Management Signal
Management is signaling focus on accelerating priority brand sales, strengthening execution in key markets, and portfolio-led growth initiatives despite challenging market conditions.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — assess sustained recovery in profitability.
Monsoon season impact — evaluate agricultural sector outlook and demand.
New product launch performance — track market acceptance and sales contribution.
MEDIUM RISK Weak monsoon, input cost pressures, and declining Seeds business present notable financial risks.
💡 Investor Takeaway
Rallis India reported Q2 FY27 revenue of Rs. 858 Cr., a marginal decrease from Rs. 861 Cr. in Q2 FY26. EBITDA decreased by 18% to Rs. 126 Cr. and PAT decreased by 17% to Rs. 85 Cr. The company highlighted challenging market conditions and input cost pressures.
⚖️ Strengths & Concerns

✅ Positives

  • Domestic Formulation Business delivered flat revenue despite challenges; Herbicides showed promising growth in Q2 FY27.
  • B2B exports including Custom Synthesis Manufacturing (CSM) revenue increased by 18% YoY in Q2 FY27.

⚠️ Concerns

  • EBITDA decreased by 18% to Rs. 126 Cr. in Q2 FY27, driven by input cost pressure and higher sales returns in Seeds.
  • PAT decreased by 17% to Rs. 85 Cr. in Q2 FY27, indicating a reduction in profitability compared to the prior year.
📅 Company Track Record
In Q1 FY27, Rallis India released an analyst call audio for unaudited financial results. For FY26, the company's profit surged 47.2% to Rs. 184 Cr., and a Rs. 3 dividend was recommended. This current filing details Q2 and H1 FY27 performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Rallis India's revenue in Q2 FY27?
Rallis India reported a revenue of Rs. 858 Cr. in Q2 FY27, a marginal decrease from Rs. 861 Cr. in Q2 FY26.
How did Rallis India's EBITDA perform in Q2 FY27?
EBITDA for Rallis India decreased by 18% to Rs. 126 Cr. in Q2 FY27, compared to Rs. 154 Cr. in Q2 FY26.
What was Rallis India's PAT in Q2 FY27?
Rallis India's PAT decreased by 17% to Rs. 85 Cr. in Q2 FY27, down from Rs. 102 Cr. in Q2 FY26.
What was the performance of Rallis India's Crop Care and Seeds segments in Q2 FY27?
Crop Care revenue increased by 4% YoY in Q2 FY27, while Seeds revenue decreased by 31% YoY for the same period.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.